Clonidine Hydrochloride Tablet, Extended Release
Product Images NDC 43547-435

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Clonidine Hydrochloride (NDC 43547-435). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Solco Healthcare Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structural Formula (Clonidine 01)

FDA Label Image

Clonidine-02.jpg (Clonidine 02)

FDA Label Image

Clonidine-03.jpg (Clonidine 03)

Clonidine-03.jpg (Clonidine 03)
The text provides a graph showing the estimated proportion of patients with treatment failure over a period of time measured in days from randomization to treatment failure. The graph compares the treatment outcomes of a drug called Clonidine Hydrochloride Extended-Release Tablet with a placebo. No further context or details are given, so it is difficult to provide a more specific description.*
FDA Label Image

Clonidine Hydrochloride Extended-release Tablets 0.1 mg (60 tablets)

Clonidine Hydrochloride Extended-release Tablets  0.1 mg (60 tablets)
This is a medication package of Clonidine Hydrochloride Extended-Release Tablets. The package contains 60 tablets and the National Drug Code (NDC) for this specific package is 43547-435-06.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.